[A new generation of urethral stents--Allium in the therapy of symptomatic prostatic enlargement of various etiology].
A number of urethral stents made of different materials, with different time of indwelling and different designs, primarily based on the vascular stent concept, have been applied in the clinical practice so far. According to the published studies, urethral stents have justified their clinical application, however with certain limitations. Within an attempt to overcome the limitations, a covered, temporary urethral stent was initially designed by Daniel Yachie and Ijko Markovi in Allium corporation from Israel. With its triangular shape, the stent is a replica of the obstructive prostatic urethral lumen. In has been applied in a series of 14 patients with lower urinary tract symptoms caused by the obstruction at the level of the prostatic urethra. The subjects were averagely aged 77.4 +/- 5.1 years. Allium prostatic stent remained in place in the patients for 4.93 +/- 3.17 months, at the average.
Marković
B B
BB
Institut za radiologiju, KC Srbije, Beograd, Srbija.
Marković
Z
Z
Yachia
D
D
Hadzi
Djokić J
DJ
D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000150:complications*; D015607:Stents; D014521:Urethra; D014524:Urethral Obstruction / Q000209:etiology / Q000628:therapy*